Novo Holdings Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 74
- Investments
- 433
- Portfolio
- 117
- Exits
- 168
Novo Holdings General Information
Description
Founded in 1999, Novo Holdings is a venture capital investment firm based in Hellerup, Denmark. The firm prefers to invest in the life sciences, oncology, digital health sectors.
Contact Information
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
- Tuborg Havnevej 19
- 2900 Hellerup
- Denmark
+45 35 00 00 00
Novo Holdings Investments (433)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| IO Biotech | 13-Jan-2021 | Later Stage VC | 00000 | Drug Discovery | Clinical Trials - Phase 3 | 0000000000 0000000000 00.0 |
| 0000000 | 06-Jan-2021 | 00000 00000 | 000.00 | Surgical Devices | Generating Revenue | 0000000000 0000000000 00.0 |
| 00000000 | 15-Dec-2020 | 00000 00000 | 000.00 | Biotechnology | Clinical Trials - Phase 2 | 0000000000 0000000000 00.0 |
| 0000000000 | 10-Dec-2020 | 0000000000 | Other Pharmaceuticals and Biotechnology | Profitable | ||
| 000000 0000 | 10-Dec-2020 | 00000 00000 | 00000 | Decision/Risk Analysis | Generating Revenue | 000000 00000000 |
| 00000 000000000000 | 09-Dec-2020 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 2 | 0000000 00000000 00.0 |
| 00000000 000000000 | 08-Dec-2020 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 1 | 0000000 00000000 00.0 |
| 00000000 00000000 | 03-Dec-2020 | 0000000000 | Enterprise Systems (Healthcare) | Generating Revenue | ||
| Den Jyske Sparekasse | 26-Nov-2020 | Buyout/LBO | 00000 | National Banks | Profitable | |
| MycoWorks | 17-Nov-2020 | Later Stage VC | 0000 | Synthetic Textiles | Generating Revenue |
Novo Holdings Exits (167)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| F-Star Therapeutics | 22-Nov-2020 | Reverse Merger | |
| 0000000 | 29-Oct-2020 | 000 | 0000 |
| 000000 00000000000 | 16-Oct-2020 | 000 | 00000 |
| 000000 | 16-Oct-2020 | 000 | 00000 |
| 000000 00000000000 | 09-Oct-2020 | 000 | 0000 |
| 000000 00000000000 | 09-Sep-2020 | 000 00 00000000 | |
| 0000000 0000000000 | 19-Aug-2020 | 000 | 00000 |
| 000000000 00000000 | 07-Aug-2020 | 000 | 0000 |
| Freeline | 07-Aug-2020 | IPO | 00000 |
| Inozyme Pharma | 24-Jul-2020 | IPO | 00000 |
Novo Holdings Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialNovo Holdings Team (131)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Kasim Kutay | Chief Executive Officer | 0 | 0 | San Francisco, CA | |
| Peter Haahr | Chief Financial Officer | 0 | Hellerup, Denmark | ||
| Christoffer Søderberg | Managing Partner and Head of Principal Investments | 0 | 0 | Hellerup, Denmark | |
| Morten Beck Jørgensen | Managing Partner, Financial Investments | 0 | 0 | Hellerup, Denmark | |
| Søren Moller Ph.D | Managing Partner, Novo Seeds | 0 | 0 | 0 | Hellerup, Denmark |
Novo Holdings Co-Investors (286)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Vivo Capital | 9 | 0 | 0 |
|
|
| New Enterprise Associates | 0 | 00 |
|
|
|
| OrbiMed | 0 | 00 |
|
|
|
| Rock Springs Capital | 0 | 0 |
|
|
|
| venBio | 0 | 00 |
|
|